Invesco’s Lunai Bioworks LNAI Stock Holding History

Invesco’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-366	Closed	-$15.9K	–	3853
2025 Q1	$15.9K	Buy	366 +3	+0.8%	+$192	﹤0.01%	3750
2024 Q4	$24.3K	Buy	363 +78	+27%	+$5.18K	﹤0.01%	3736
2024 Q3	$11K	Sell	285 -2	-0.7%	-$139	﹤0.01%	3746
2024 Q2	$40.2K	Buy	+287	New	+$39.1K	﹤0.01%	3838
2023 Q2	–	Sell	-1,262	Closed	-$92.4K	–	3929
2023 Q1	$92.4K	Sell	1,262 -6	-0.5%	-$528	﹤0.01%	3711
2022 Q4	$104K	Hold	1,268	–	–	﹤0.01%	3814
2022 Q3	$183K	Hold	1,268	–	–	﹤0.01%	3706
2022 Q2	$196K	Sell	1,268 -1,375	-52%	-$629K	﹤0.01%	3733
2022 Q1	$1.74M	Buy	+2,643	New	+$1.41M	﹤0.01%	2839
2021 Q4	–	Sell	-3,176	Closed	-$1.71M	–	4094
2021 Q3	$1.71M	Buy	+3,176	New	+$1.55M	﹤0.01%	2890
2021 Q2	–	Sell	-244	Closed	-$69K	–	4021
2021 Q1	$69K	Buy	244 +5	+2%	+$1.47K	﹤0.01%	3806
2020 Q4	$56K	Buy	+239	New	+$60.4K	﹤0.01%	3731

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Invesco's LNAI Position: Q2 2025 in Review

Invesco sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 366 shares — an estimated $15.9K sold.

Invesco first reported a position in LNAI in Q4 2020 and held it in 12 quarters. The position peaked at $1.74M in Q1 2022. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

Invesco reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
Invesco sold 366 Lunai Bioworks shares in Q2 2025, an estimated $15.9K.
Invesco first reported a position in Lunai Bioworks in Q4 2020 and held it in 12 quarters.
Invesco's Lunai Bioworks position peaked at $1.74M in Q1 2022.
42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.